{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009378126,0.0004379216,0.0006613116,0.0002588308,0.0003695902,0.000536709,0.0003216888,0.0005226037,0.002004848],"category_scores_gemma":[0.001315511,0.0000863233,0.0005432459,0.0005766906,0.0001777523,0.0005396249,0.0003604813,0.001306538,0.00123933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003861242,"about_ca_system_score_gemma":0.0003643553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586868,"about_ca_topic_score_gemma":0.0009987525,"domain_scores_codex":[0.9996983,0.0001004302,0.00004175764,0.00005006068,0.00006923894,0.0000402696],"domain_scores_gemma":[0.9996642,0.0001071583,0.00004904624,0.00002145915,0.00005552296,0.000102609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003489265,0.001386811,0.0119694,0.001749311,0.0004359554,0.00268783,0.0004755029,0.0004776198,0.008764334,0.0006420664,0.02031329,0.9476086],"study_design_scores_gemma":[0.00503716,0.03713548,0.1349536,0.00243761,0.001916373,0.05400372,0.0005445863,0.001563983,0.01893763,0.001317016,0.7420037,0.0001491462],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2974916,0.6627792,0.002524053,0.007054506,0.001547559,0.0002606453,0.0008576413,0.0001354293,0.02734931],"genre_scores_gemma":[0.6515679,0.3217292,0.002287752,0.006936184,0.001727115,0.000186133,0.002551914,0.00006859504,0.01294532],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002004848,"threshold_uncertainty_score":0.006706953,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03141548310013683,"score_gpt":0.4158838494868783,"score_spread":0.3844683663867415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}